FDA warns companies illegally selling CBD products to treat medical conditions, opioid addiction

4/23/20–The U.S. Food and Drug Administration has issued warning letters to two companies for illegally selling unapproved products containing cannabidiol (CBD) in ways that violate the Federal Food, Drug and Cosmetic Act (FD&C Act). Read